Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.52 |
| ▸ | CNR2 | P34972 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7440853 | 0.82 | CNR1 (0.52) | CNR1CNR2ALDH1A1LMNACHRM1 | |
| SCHEMBL8635323 | 0.81 | CNR1 (0.49) | CNR1CNR2ALDH1A1LMNACHRM1 | |
| SCHEMBL7399588 | 0.73 | METAP1 (0.45) | CNR1CNR2ALDH1A1PLA2G2A | |
| SCHEMBL7962690 | 0.68 | PLA2G2A (0.74) | ALDH1A1LMNAPLA2G2A | |
| SCHEMBL7401051 | 0.68 | DRD4 (0.42) | LMNASMN1; SMN2PLA2G2A | |
| SCHEMBL11093641 | 0.68 | GAA (0.72) | ALDH1A1LMNAGAASMN1; SMN2L3MBTL1 | |
| SCHEMBL8356932 | 0.68 | LMNA (0.73) | CNR1CNR2ALDH1A1LMNACHRM1 | |
| SCHEMBL11361199 | 0.67 | ALDH1A1 (0.53) | ALDH1A1LMNAGAASMN1; SMN2L3MBTL1 | |
| SCHEMBL7475308 | 0.67 | ALDH1A1 (0.70) | ALDH1A1GAASMN1; SMN2L3MBTL1POLB | |
| SCHEMBL1548594 | 0.67 | CHRM1 (0.76) | ALDH1A1LMNACHRM1SMN1; SMN2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5753659-A | ANTICOAGULANTS FOR BLOOD DISORDER, CARDIOVASCULAR DISORDER, THROMBOSIS, | ZENECA LIMITED (GB) | 1998-05-19 | — | — | US | disclosed |
| US-5750754-A | TERTIARY BUTYL 3-METHYL-4-SUBSTITUTED BUTYRATE; CHEMICAL INTERMEDIATES FOR ANTICAOGULANT DRUGS | ZENECA LIMITED (GB) | 1998-05-12 | — | — | US | disclosed |
| US-5563141-A | INHIBIT CELL ADHESION FOR EXAMPLE, PLATELET AGGRE GATION | ZENECA LIMITED (GB) | 1996-10-08 | — | — | US | disclosed |
| EP-0690847-A1 | HETEROCYCLIC COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | ZENECA LIMITED (GB) | 1996-01-10 | — | — | EP | disclosed |
| WO-1994022835-A2 | HETEROCYCLIC COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | ZENECA LIMITED (GB) | 1994-10-13 | — | — | WO | disclosed |